CN101843645B - Chinese medicament for treating tachycardia - Google Patents

Chinese medicament for treating tachycardia Download PDF

Info

Publication number
CN101843645B
CN101843645B CN2009102383106A CN200910238310A CN101843645B CN 101843645 B CN101843645 B CN 101843645B CN 2009102383106 A CN2009102383106 A CN 2009102383106A CN 200910238310 A CN200910238310 A CN 200910238310A CN 101843645 B CN101843645 B CN 101843645B
Authority
CN
China
Prior art keywords
chinese medicine
parts
chinese medicament
tachycardia
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102383106A
Other languages
Chinese (zh)
Other versions
CN101843645A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rugao Binjiang Urban Construction Investment Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383106A priority Critical patent/CN101843645B/en
Publication of CN101843645A publication Critical patent/CN101843645A/en
Application granted granted Critical
Publication of CN101843645B publication Critical patent/CN101843645B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicament for treating tachycardia, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: storax, lucid ganoderma, radix pseudo-ginseng and Szechuan lovage rhizome. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and nourishing heart, soothing nerve and freeing vessels, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗心动过速的中药A traditional Chinese medicine for treating tachycardia

技术领域technical field

本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.

背景技术Background technique

目前旨在治疗心动过速的中药领域,存在一些不足:一是效果不够明显,二是见效比较迟缓。以致于许多心动过速的中老年人长期受心慌、心悸、胸闷、心跳过快的折磨,严重影响了生活质量,患者及其家属对此不够满意。At present, there are some shortcomings in the field of traditional Chinese medicine aimed at treating tachycardia: the first is that the effect is not obvious enough, and the second is that the effect is relatively slow. As a result, many middle-aged and elderly people with tachycardia suffer from palpitation, heart palpitations, chest tightness, and rapid heartbeat for a long time, which seriously affects the quality of life, and patients and their families are not satisfied with this.

针对以上提出的问题,本发明提供一种治疗心动过速的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for the treatment of tachycardia, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and the effect is relatively slow. The advantage of being faster.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗心动过速的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of tachycardia, adopts Chinese medicine raw material to prepare, and formula is (by weight):

苏合香3-20份    灵芝2-12份    三七3-20份Styrax 3-20 parts Ganoderma lucidum 2-12 parts Panax notoginseng 3-20 parts

川芎4-30份Chuanxiong 4-30 parts

这种治疗心动过速的中药是由下列方法制成的:This traditional Chinese medicine for treating tachycardia is made by the following method:

(1)按上述重量比,将川芎经常规水提取工艺提取,制成浸膏细粉;(1) according to the above weight ratio, Ligusticum chuanxiong is extracted through a conventional water extraction process to make a fine powder of extract;

(2)按上述重量比,将苏合香、灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind styrax, ganoderma lucidum, and Panax notoginseng into fine powders, mix them with the above extract powders, and stir evenly; Dosage forms such as pills and tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝益气养血,养心安神,扶正培本,增强机体免疫力;川芎、三七养血活血,化瘀止痛;配伍苏合香芳香开窍,解郁化痰,以安心养脉,缓解心动过速。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,养心安神通脉之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum nourishes Qi and blood, nourishes the heart and calms the nerves, strengthens the body and strengthens the body's immunity; Chuanxiong and Panax notoginseng nourish blood and activate blood, remove blood stasis and relieve pain; it is combined with the aroma of Styrax to rejuvenate, relieve stagnation and phlegm, soothe the heart and nourish the pulse, and relieve heartbeat Excessive speed. All the medicines are compatible and complement each other, and they play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, nourishing the heart, calming the nerves and dredging the veins. The effect is good, and the effect is fast.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

苏合香60克    灵芝40克    三七60克Styrax 60g Ganoderma lucidum 40g Panax notoginseng 60g

川芎80克Chuanxiong 80g

按规定重量,用常规水提取工艺将川芎提取,制成浸膏细粉24克,将苏合香、灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊657粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, extract Chuanxiong with conventional water extraction process to make 24 grams of fine powder of extract, grind storax, ganoderma lucidum, and Panax notoginseng into fine powder respectively, mix with the fine powder of extract above, stir evenly, and make fine particles , pack into No. 0 capsules, make 657 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and extract 0.28 grams.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

苏合香90克    灵芝60克    三七90克Styrax 90g Ganoderma lucidum 60g Panax notoginseng 90g

川芎160克Chuanxiong 160g

按上述同样的方法,制成中药胶囊1028粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, 1028 Chinese medicine capsules were made, and each capsule contained Chinese medicine fine powder and 0.28 grams of extract.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

苏合香200克    灵芝120克    三七200克Styrax 200g Ganoderma lucidum 120g Panax notoginseng 200g

川芎300克Chuanxiong 300g

按上述同样的方法,制成中药胶囊2178粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2178 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

苏合香6份    灵芝4份    三七6份Styrax 6 parts Ganoderma lucidum 4 parts Panax notoginseng 6 parts

川芎8份Chuanxiong 8 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

苏合香15份    灵芝8份    三七15份Styrax 15 parts Ganoderma lucidum 8 parts Panax notoginseng 15 parts

川芎25份Chuanxiong 25 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医心动过速为例,经8例临床观察。选择中医诊断心悸、心动过速为标准:发作时脉搏过快,心慌心乱,胸部胀闷,四肢发麻,肢软乏力,心率160次/分钟左右。如上症状,即可确诊。在确诊观察的对象中,男性5例,女性3例,无其它严重疾病,年龄为41岁-80岁,平均年龄64.2岁。The present invention takes TCM tachycardia as an example, through 8 clinical observations. TCM diagnosis of palpitations and tachycardia was selected as the standard: the pulse was too fast during the attack, palpitation and confusion, chest distension, numbness of the limbs, weakness and weakness of the limbs, and the heart rate was about 160 beats/min. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 5 males and 3 females, without other serious diseases, aged from 41 to 80 years old, with an average age of 64.2 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,四肢有劲,心慌心悸等心区不适明显缓解或消失,心区舒适,心率100次/分钟以下。1. Significant effect: Physical fitness is enhanced, limbs are strong, palpitations and palpitations and other heart discomfort are obviously relieved or disappeared, the heart area is comfortable, and the heart rate is below 100 beats/min.

2、有效:体质增强,心慌心悸等心区不适有所缓解。2. Effective: physical fitness is strengthened, palpitation and heart palpitations are alleviated.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的8人中,显效4人,有效3人,无效1人,总有效率87.5%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 8 people in the clinical trial, 4 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 87.5%.

Claims (1)

1.一种治疗心动过速的中药,其特征是,它是以下列重量比的中药原料制备而成的:1. a kind of Chinese medicine for the treatment of tachycardia is characterized in that it is prepared from the Chinese medicine raw material of following weight ratio: 苏合香3-20份    灵芝2-12份    三七3-20份Styrax 3-20 parts Ganoderma lucidum 2-12 parts Panax notoginseng 3-20 parts 川芎4-30份Chuanxiong 4-30 parts 这种治疗心动过速的中药是由下列方法制成的:This traditional Chinese medicine for treating tachycardia is made by the following method: (1)按上述重量比,将川芎经常规水提取工艺提取,制成浸膏细粉;(1) according to the above weight ratio, Ligusticum chuanxiong is extracted through a conventional water extraction process to make a fine powder of extract; (2)按上述重量比,将苏合香、灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药颗粒剂、散剂、胶囊剂、水丸剂、片剂剂型。(2) According to the above weight ratio, grind styrax, ganoderma lucidum and notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into traditional Chinese medicine granules, powders, capsules, water pills, Tablet dosage form.
CN2009102383106A 2009-11-18 2009-11-18 Chinese medicament for treating tachycardia Expired - Fee Related CN101843645B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383106A CN101843645B (en) 2009-11-18 2009-11-18 Chinese medicament for treating tachycardia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383106A CN101843645B (en) 2009-11-18 2009-11-18 Chinese medicament for treating tachycardia

Publications (2)

Publication Number Publication Date
CN101843645A CN101843645A (en) 2010-09-29
CN101843645B true CN101843645B (en) 2011-07-20

Family

ID=42768580

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383106A Expired - Fee Related CN101843645B (en) 2009-11-18 2009-11-18 Chinese medicament for treating tachycardia

Country Status (1)

Country Link
CN (1) CN101843645B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081890A (en) * 1993-02-17 1994-02-16 中国人民解放军第二炮兵西安中医多学科研究所 The prescription and the production method of treatment angina pectoris coronary heart disease medicine
CN101084959A (en) * 2006-06-08 2007-12-12 天津天士力制药股份有限公司 Traditional Chinese medicinal composition containing ligusticum wallichii, notoginseng and borneol or storax and preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081890A (en) * 1993-02-17 1994-02-16 中国人民解放军第二炮兵西安中医多学科研究所 The prescription and the production method of treatment angina pectoris coronary heart disease medicine
CN101084959A (en) * 2006-06-08 2007-12-12 天津天士力制药股份有限公司 Traditional Chinese medicinal composition containing ligusticum wallichii, notoginseng and borneol or storax and preparation thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王亚峰.《心舒胶囊治疗冠心病46例疗效观察》.《中西医结合心脑血管病杂志》.2005,第3卷(第5期),446-447. *
郑梅生.《中医药治疗冠心病心律失常的临床研究述评》.《中国中医基础医学杂志》.1999,第5卷(第7期),3-5. *

Also Published As

Publication number Publication date
CN101843645A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843661B (en) Chinese medicament for treating angina
CN101843828A (en) Chinese medicament for treating climacteric syndromes
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843712B (en) Chinese medicament for treating angina
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN101843753B (en) Chinese medicament for treating angina
CN101843793B (en) Chinese medicament for treating tachycardia
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843720B (en) Chinese medicament for treating angina
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843786A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101843645A (en) Chinese medicament for treating tachycardia
CN101843831B (en) Chinese medicament for treating diabetic cardiopathy
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101843646A (en) Chinese medicament for treating tachycardia
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843708A (en) Chinese medicament for treating cervical spondylosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166.

Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110720

Termination date: 20151118

EXPY Termination of patent right or utility model